Wedmont Private Capital Purchases 28,006 Shares of Danaher Corporation $DHR

Wedmont Private Capital grew its position in shares of Danaher Corporation (NYSE:DHR) by 939.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 30,988 shares of the conglomerate’s stock after buying an additional 28,006 shares during the period. Wedmont Private Capital’s holdings in Danaher were worth $6,865,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the company. Main Street Group LTD acquired a new position in shares of Danaher in the first quarter worth about $25,000. N.E.W. Advisory Services LLC acquired a new stake in shares of Danaher during the 2nd quarter valued at about $25,000. Hilton Head Capital Partners LLC purchased a new position in shares of Danaher in the 4th quarter valued at about $27,000. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares in the last quarter. Finally, Evolution Wealth Management Inc. raised its holdings in Danaher by 208.0% in the 1st quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 104 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Price Performance

NYSE DHR traded up $2.82 during mid-day trading on Friday, hitting $220.28. The stock had a trading volume of 1,215,501 shares, compared to its average volume of 4,447,280. The firm’s 50 day moving average is $210.88 and its 200 day moving average is $194.44. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The stock has a market capitalization of $154.85 billion, a price-to-earnings ratio of 39.08, a PEG ratio of 2.72 and a beta of 0.76. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter in the previous year, the company posted $0.77 EPS. The firm’s quarterly revenue was up 5.5% on a year-over-year basis. Equities research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.40 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio is presently 28.42%.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. Royal Bank Of Canada raised their price objective on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday. TD Cowen decreased their target price on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Wells Fargo & Company dropped their price target on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. The Goldman Sachs Group upped their price objective on shares of Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Finally, Evercore reaffirmed an “outperform” rating and set a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. Two analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $235.23.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.